With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.4603-59-2,3,6-Dimethoxypyridazine,as a common compound, the synthetic route is as follows.
4-Chloro-3,6-dimethoxy-pyridazine: A solution of n-butyllithium (1.6 M in hexanes, 2.45 mL, 3.92 mmol) was added to a cold solution of THF (20 mL) at -78 C. Tetramethylpiperidine (0.67 mL, 3.92 mol) was introduced and the solution was warmed to 0 C. and kept at this temperature for 20 min; it was then cooled to -78 C. A solution of 3,6-dimethoxy-pyridazine (500 mg, 3.57 mmol) in THF (5 mL) was added slowly and the mixture was stirred at -78 C. for 45 min. This reaction mixture was transferred to a solution of achloroethane (1.268 g, 5.36 mmol) in THF (10 mL) at -78 C. and stirring was continued at -78 C. for 15 min. Saturated aqueous NH4Cl was added and the mixture was warmed to room temperature. The mixture was extracted with EtOAc, dried over MgSO4, and concentrated in vacuo to give the crude product, which was purified by flash chromatography, eluding with 10-20% EtOAc in hexanes to afford, after evaporation, the title compound as a white solid (372 mg, 60%): 1H NMR (400 MHz, DMSO) delta 7.04 (s, 1H), 4.11 (s, 3H), 4.04 (s, 3H); LCMS (+ESI, M+H+) m/z 175., 4603-59-2
The synthetic route of 4603-59-2 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; Beaulieu, Francis; Marinier, Anne; Ouellet, Carl; Roy, Stephan; Wittman, Mark D.; US2005/54655; (2005); A1;,
Pyridazine – Wikipedia
Pyridazine | C4H4N2 – PubChem